An 18 Week Efficacy and Safety Study of Saxagliptin and Metformin XR Combination in Subjects With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

282

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
Type 2 Diabetes
Interventions
DRUG

Saxagliptin

5mg oral tablet once daily

DRUG

Metformin XR

500mg oral tablet once daily

DRUG

Metformin XR

750mg, 2 tablets once daily

Trial Locations (35)

Unknown

Research Site, Jonesboro

Research Site, Anaheim

Research Site, Fountain Valley

Research Site, Los Angeles

Research Site, Pasadena

Research Site, Sacramento

Research Site, Gainesville

Research Site, Wellington

Research Site, Chicago

Research Site, Springfield

Research Site, Indianapolis

Research Site, St Louis

Research Site, Salisbury

Research Site, Wilmington

Research Site, Winston-Salem

Research Site, Columbus

Research Site, Marion

Research Site, Simpsonville

Research Site, Bristol

Research Site, Alexandria

Research Site, Burke

Research Site, Manassas

Research Site, Barranquilla

Research Site, Barranquilla

Research Site, Bogotá

Research Site, Curridabat

Research Site, Los Yoses

Research Site, Heredia

Research Site, México

Research Site, Durango

Research Site, Guadalajara

Research Site, Zapopan

Research Site, Cuernavaca

Research Site, Querétaro City

Research Site, Lima

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

AstraZeneca

INDUSTRY